E75.2
Other sphingolipidosis
Clinical Classification Guidelines
Excludes Type 1
- adrenoleukodystrophy [Addison-Schilder] (E71.528)
Medical Intelligence & Overview
Other sphingolipidosis is a group of rare inherited disorders characterized by the abnormal accumulation of sphingolipids, a type of fat, within various cells of the body. This buildup occurs due to enzyme deficiencies necessary for breaking down these fats. The condition can affect multiple organs and tissues, leading to diverse health issues. Although it is classified as a rare disease, understanding its features can help in managing and recognizing the disorder early.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents Deficiency of specific enzymes needed to break down sphingolipids Accumulation of sphingolipids in cells due to enzyme malfunction
Key Symptoms: Organ enlargement, such as liver or spleen (hepatosplenomegaly) Muscle weakness or fatigue Skin changes, including pigmentary abnormalities Neurological difficulties like seizures or coordination problems Developmental delays in children Eye problems, including cloudy vision or abnormal eye movements Bone abnormalities or pain
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, laboratory tests, and genetic assessments. Blood tests can measure enzyme activity levels, while tissue biopsies may reveal the accumulation of sphingolipids. Genetic testing helps identify specific mutations responsible for the disorder. Imaging studies may be used to assess organ involvement, and neurological evaluations are performed if nerve or brain symptoms are present.
Treatment Protocols: Currently, there is no cure for other sphingolipidosis. Treatment mainly focuses on managing symptoms and preventing complications. This can include enzyme replacement therapy in some types, supportive therapies like physical and occupational therapy, and medications to alleviate specific symptoms. Regular monitoring and multidisciplinary medical care are essential for optimal management. Research continues toward developing targeted therapies for these conditions.
Clinical Advice & FAQs
Billing Guidance
Is E75.2 a billable ICD-10 code?
Yes, E75.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E75.2?
Clinical documentation must specify the nature of Other sphingolipidosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference